Clinical trial / 2018
Gastrointestinal symptoms were more frequent with higher doses of D-allulose in adults
In a non-randomized controlled trial, young adults underwent gastrointestinal tolerance tests with stepwise dose escalations of D-allulose. No severe diarrhea or gastrointestinal symptoms appeared up to 0.4 g/kg body weight, but severe diarrhea occurred at 0.5 g/kg body weight. Compared to sugar, D-allulose was linked to higher frequencies of diarrhea (p = 0.004), abdominal distention (p = 0.039), and abdominal pain (p = 0.031), while escalating total daily intake to 1.0 g/kg body weight produced severe nausea, headache, anorexia, and diarrhea.
- Study type
- Non-randomized controlled trial
- Who was studied
- Healthy young adults
- What was measured
- Gastrointestinal tolerance thresholds and gastrointestinal symptoms
THE PAPER
Gastrointestinal Tolerance of D-Allulose in Healthy and Young Adults. A Non-Randomized Controlled Trial.
Han Y, Choi BR, Kim SY, Kim SB, Kim YH, Kwon EY, Choi MS. Nutrients, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.